Buy or sell WuXi NextCODE stock pre IPO via an EquityZen fund
WuXi NextCODE Stock
Using genomic information to improve health
About WuXi NextCODE Stock
WuXi NextCODE is a fully integrated contract genomics organization building the global standard platform for genomic data. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we serve the leading population genomics, precision medicine, diagnostics and wellness initiatives and enterprises using the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a WuXi Group company.
Nexus Investment Ventures
Hannes Thor Smárason
President and Chief Scientific Officer